Search

everythinglearnresearchcommunity

for

Search:↓

PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.

A user successfully regrew hair using oral finasteride (1mg daily for 3 years) and topical minoxidil (5% twice daily for 15 years) with no side effects. They highlighted the importance of consistency and patience, crediting finasteride for significant hair improvement.

A user shared their hair loss journey, using finasteride since age 18 and adding dutasteride at 30, which halted hair loss and promoted regrowth. They take finasteride daily and dutasteride three times a week, experiencing reduced libido and drier skin as side effects.

A 30-year-old man saw improved hair density and texture after three months using Minoxidil, Finasteride, and ketoconazole shampoo, despite initial side effects. He experienced increased body hair and libido and is satisfied with the results despite the high cost in Turkey.

DHT is not the only cause of male pattern hair loss; genetic sensitivity, inflammation, and fibrosis also contribute. GHK-Cu, a copper peptide, is being explored as an alternative treatment to finasteride and minoxidil, showing potential in improving follicle health.

Oral minoxidil dosing should be based on body weight to minimize side effects, with higher doses increasing risks like pericardial effusion. Combining oral minoxidil with topical treatments and finasteride can improve hair growth, but regular heart health monitoring is essential.

A 20-year-old FTM individual started finasteride for hair loss with initial success but experienced increased shedding after 7 months. They are considering oral minoxidil as advised by their doctor to address the worsening hair loss.

A dermatologist prescribed 0.625mg of oral minoxidil daily without a DHT blocker, which some users disagree with, suggesting a combination with finasteride or dutasteride for better results. Others argue starting with a low dose of minoxidil is standard to test tolerance before considering additional treatments.

A 34-year-old man has used finasteride for 10 years and dutasteride for 1 year to manage hair loss, experiencing minimal side effects and slight hair thinning. He plans to continue using finasteride, ketoconazole shampoo, and oral liquid finasteride, noting that cost and convenience influenced his dosage choices.

Finasteride may affect male offspring's fertility and hormonal balance, with debates on whether to discontinue use before conception. Some users report no issues, while others highlight the high doses used in rat studies.

Inconsistent minoxidil use led to hair loss, prompting a plan to resume consistent application with derma stamping, red light therapy, and DHT blockers like clascoterone or RU58841. The user avoids finasteride and dutasteride due to past side effects.

An 18-year-old experiencing aggressive hair loss has been using 1mg finasteride and 2.5mg oral minoxidil for 162 days but continues to shed hair. Suggestions include switching to dutasteride, considering topical minoxidil, and consulting a dermatologist for further evaluation.

Oral minoxidil can cause cardiovascular issues, but an extended release formulation may reduce side effects like heart rate and blood pressure spikes. This new formulation offers a safer option for those who previously had to stop due to health concerns.

Copper peptides may help with hair thickness and health, but their effectiveness in reducing DHT is uncertain. Minoxidil is being used, but finasteride is not available due to legal restrictions; ketoconazole shampoo is recommended for managing Malassezia-related issues.

A user shared their positive experience 9.5 months after a hair transplant at Diamond Hair Clinic in Istanbul, Turkey, mentioning the use of dutasteride, vitamin tablets, and minoxidil shampoo. They expressed satisfaction with the procedure and would choose to do it again.

There is no permanent cure for hair loss; treatments like finasteride, minoxidil, and hair transplants require ongoing use and are not universally effective. Genetic complexity and financial incentives for ongoing treatments hinder the development of a definitive cure.

The conversation discusses increasing the dose of oral minoxidil from 2.5mg to 5mg for better hair density, with concerns about potential side effects like heart rate changes and fluid retention. Users suggest consulting a doctor, considering individual tolerance, and exploring other treatments like dutasteride.

The user has been taking finasteride daily for almost two years, starting at age 25, and has experienced stabilization and minor regrowth in hair loss without significant side effects, except for increased urination. They encourage others dealing with hair loss to consider treatment options and not be discouraged by varying response times.

The user experienced noticeable hair regrowth after one year using finasteride and minoxidil, with improvements seen around 5-6 months. They report no side effects and use liquid minoxidil twice daily.

A 25-year-old male with androgenetic alopecia experienced improved hair condition after using finasteride, oral minoxidil, and dutasteride, but later faced diffuse thinning and texture deterioration after a shedding phase. Others suggest patience, continued treatment, and using ketoconazole shampoo, with some sharing similar experiences of post-shed thinning.

The user reported improved hair density using Dutasteride 0.5mg and Oral Minoxidil 3.75mg, along with Nizoral shampoo and oils. There was debate about the validity of the progress due to differences in lighting and angles in the photos.

Red light therapy has shown promising results in hair regrowth for the user, who avoids minoxidil and finasteride due to side effects. The user follows a healthy lifestyle with diet, exercise, and sauna use, and will continue monitoring the therapy's effectiveness.

The user is considering continuing minoxidil and microneedling, possibly adding low-dose topical finasteride, and undergoing a large FUE hair transplant to improve hair appearance. They plan to use hair fibers for added density, aiming for a convincing cosmetic look rather than full density.

A user shared their hair regrowth journey from ages 31 to 39, using finasteride, oral and topical minoxidil, and dutasteride. They experienced significant hair density improvement and temple regrowth, with increased hair growth as the only side effect.

A user shares optimism about combating male pattern baldness using oral and topical minoxidil, highlighting the advancements in treatments available today. Another user agrees, noting that early treatment can yield good results, and mentions the availability of affordable hair transplants.

OP is using finasteride and minoxidil for hair loss but hasn't seen results after four months. Users advise that noticeable results typically take a year or more, and suggest daily dosing for effectiveness.

A young person regrets not starting hair loss treatments like minoxidil and finasteride earlier, leading to significant balding by age 19. They discuss the importance of early intervention and the impact of societal perceptions on those experiencing hair loss.

The user experienced initial hair regrowth with 1 mg finasteride and 5 mg minoxidil but began shedding after 4-5 months, which others suggest is common and may lead to thicker regrowth. Users recommend patience, as results can take up to 12-24 months, and suggest considering specialized clinics for hairline design if unsatisfied with medication alone.

A 17-year-old is stressed about mild male pattern baldness and is considering treatments like minoxidil and finasteride but is concerned about starting finasteride too young. Users suggest starting with minoxidil and considering finasteride at 18, while emphasizing the importance of consulting a doctor and not obsessing over hair loss.

PP405 is a promising experimental topical treatment for alopecia that reactivates dormant hair follicles by targeting cellular energy, with large-scale trials planned for 2026. While it shows potential, it cannot regenerate permanently destroyed follicles, making hair transplants the only guaranteed solution for advanced baldness currently.